Collectively, these findings indicate that IL-10 not only exerts direct anti-inflammatory effects in AR but may also modulate metabolic pathways to mitigate disease progression, highlighting IL-10-mediated metabolic regulation as a potential therapeutic target in allergic diseases. This evidence concerns the gene IL10 and allergic disease.